In an interview with Alcedis*, our CEO, Dr. Tobias Kruse, discussed how Trials24 revolutionizes patient recruitment for clinical trials.
Emphasizing the importance of targeted online awareness campaigns, Dr. Kruse explained Trials24’s approach to reaching potential patients through platforms like Google and Facebook. He highlighted the effectiveness of our online pre-screening process and patient awareness campaigns, which include diverse age groups. Trials24’s techniques significantly reduce recruitment risks, especially in rare disease studies, by connecting with individuals who might never learn about these clinical trials.
To learn more and see the original interview in German, please go here.
If you have any questions about this interview or need to shorten your patient recruitment timeline, please contact us here.
*Alcedis organizes data-driven clinical trials worldwide and drives digital clinical research by focusing on technology.
Image from: Trials24 Marketing Department
Trials24 GmbH
Trials24 accelerates patient recruitment to support biopharmaceutical companies and CROs complete their clinical trials on time, bringing innovative drugs to patients faster.
© Copyright | Trials24 GmbH